Amarantus Bioscience Holdings Inc (AMBS)

[newflow]

ELTOPRAZINE STATUS CHANGED TO ACTIVE FROM SUSPENDED

Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, 4-way Crossover, Dose-finding Study, of Eltoprazine Safety, Tolerability and Efficacy in the Treatment of Levodopa-induced Dyskinesia in Patients With Parkinson's Disease
Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 25 Apr 2016


At a glance

Drugs
Eltoprazine (Primary)
Indications
Drug-induced dyskinesia
Focus
Therapeutic Use
Sponsors
Amarantus Bioscience Holdings
Most Recent Events
20 Apr 2016
Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
20 Apr 2016
Planned primary completion date changed from 1 Jun 2016 to 1 Jun 2017.
20 Apr 2016
Status changed from suspended to active, no longer recruiting.